PRC1 and liposarcoma: Functional assay revealed that miR-143 could repress the expressions of topoisomerase 2-alpha (TOP2A), protein regulator of cytokinesis 1 (PRC1), and polo-like kinase 1 (PLK1) to inhibit liposarcoma cell growth and trigger apoptosis [90].